Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease
Jung-Kyu Lee,1 Chin Kook Rhee,2 Kyungjoo Kim,2 Seung Won Ra,3 Jae Ha Lee,4 Ki-Suck Jung,5 Kwang Ha Yoo,6 Yoo-Il Kim,7 Deog Kyeom Kim1 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Se...
Main Authors: | Lee JK, Rhee CK, Kim K, Ra SW, Lee JH, Jung KS, Yoo KH, Kim YI, Kim DK |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-11-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/prescription-status-and-clinical-outcomes-of-methylxanthines-and-leuko-peer-reviewed-article-COPD |
Similar Items
-
The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
by: Ludwig Aigner, et al.
Published: (2020-12-01) -
Comparative Study to Assess Clinical Efficacy of Leukotriene Receptor Antagonist and Antihistamines in the Treatment of Allergic Rhinitis
by: Gurpreet Kaur, et al.
Published: (2017-08-01) -
Comparative Study to Assess Clinical Efficacy of Leukotriene Receptor Antagonist and Antihistamines in the Treatment of Allergic Rhinitis
by: Gurpreet Kaur, et al.
Published: (2017-08-01) -
Methylxanthines accumulation in Ilex species - caffeine and theobromine in erva-mate (Ilex paraguariensis) and other Ilex species
by: Reginatto F.H., et al.
Published: (1999-01-01) -
Update on leukotriene receptor antagonists in preschool children wheezing disorders
by: Montella Silvia, et al.
Published: (2012-06-01)